FDA Inspection 828678 — Curium US, LLC
The FDA completed an inspection of Curium US, LLC on March 27, 2013 in Maryland Heights, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 27, 2013
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Maryland Heights, MO (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)